Program to Support New Implementation of State or Territorial Public Health Laboratory Capacity for Newborn Bloodspot Screening of Severe Combined Immune Deficiency (SCID)

Archived

Centers for Disease Control and Prevention - ERA

Description

The purpose of this funding opportunity is to promote research in support of the implementation of first time newborn bloodspot screening programs for SCID and is targeted to programs which were not fully operational before January 2011.Objectives:� To expand laboratory capacity for SCID newborn screening in the US by the funding of capital costs for purchases (such as laboratory equipment, reagents, etc) in order to implement SCID testing� To increase the pool of laboratory scientists with knowledge and skill in conducting newborn screening for SCID� To provide training for the public health community (e.g., laboratory scientists, healthcare providers, NBS program officials, primary care physicians) about NBS tests for SCID and to foster its integration into the standard of care for communities � To encourage participation in collaborative ventures to explore data analysis and statistical algorithms that can improve the predictive values of primary SCID NBS tests Note: Awards are intended as seed funding, and applicants must demonstrate a commitment to secure and sustain funds from other sources for routine program operation beyond the project period.

Who can apply

  • Others

Contact

Centers for Disease Control and Prevention <br/>Procurement and Grants Office <br/>TIMS <br/>Phone 770-488-2700
PGOTIM@cdc.gov

Key dates & funding
  • PostedMar 17, 2011
  • ClosesMay 31, 2011
  • Award floor$0
  • Award ceiling$450,000
  • Program funding$900,000
  • Expected awards2
  • CFDA93.065
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro